RNA — Atrium Therapeutics, Inc.

RNAAtrium Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · atriumtherapeutics.com

12.77USD-2.41%Mkt Cap: 216.81M USDP/E: —Last update: 2026-06-01

Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stag…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap216.81M USD

Enterprise Value-42.80M USD

Revenue (TTM)36.68M USD

Gross Profit-12.07M USD

Net Income (TTM)-76.68M USD

Revenue/Share2.144 USD

Last Price12.77 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees—

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-3.22

PEG—

EV/EBITDA0.72

EV/Revenue-1.17

P/S6.06

P/B-3.22

EPS (TTM)-5.02

EPS (Forward)-4.03

52W Range

11.9517% of range16.77

52W High16.77 USD

52W Low11.95 USD

Profitability

Gross Margin-32.91%

Oper. Margin-88.01%

EBITDA Margin-160.95%

Profit Margin-411.88%

ROE-36.99%

ROA-27.55%

Growth

Revenue Growth1148.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF-41.13M USD

CapEx (TTM)1.45M USD

FCF Margin—

FCF Yield—

Net Debt-265.17M USD

Net Debt/EBITDA4.49

Balance Sheet

Debt/Equity0.02

Current Ratio13.04

Quick Ratio12.91

Book Value/Sh-4.0420 USD

Cash/Share15.66 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)25.00 USD

Target Range25.00 USD – 25.00 USD

# Analysts2

Ownership

Shares Out.17.11M

Float15.76M

Insiders4.27%

Institutions87.68%

Short Interest

Short Ratio12.3d

Short % Out.21.82%

Shares Short3.43M

Short (prev mo.)3.02M

Technical

SMA 5013.29 (-4.0%)

SMA 20013.60 (-6.1%)

Beta—

S&P 52W Chg27.70%

Avg Vol (30d)246.31K

Avg Vol (10d)215.29K

Technical Indicators

RSI (14)48.0

MACD-0.0822

MACD Signal-0.1230

MACD Hist.+0.0409

BB Upper13.46 USD

BB Middle13.09 USD

BB Lower12.72 USD

BB Width5.70%

ATR (14)0.5589 USD

Vol Ratio (20d)1.09x